World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
49207
World Ranking
9878
National Ranking
386

Overview

Emiel J. Th. Rutgers is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with focused contributions in Cancer Research and Oncology. The scientist's work also intersects with Pulmonary and Respiratory Medicine, Genetics, and Molecular Biology as subfields of interest.

The main topics covered in their research include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Breast Lesions and Carcinomas
  • HER2/EGFR in Cancer Research
  • Breast Implant and Reconstruction

Emiel J. Th. Rutgers has frequently collaborated with several co-authors including Fátima Cardoso, Coralie Poncet, Martine Piccart, Laura van 't Veer, and Suzette Delaloge. This collaborative work has been published across multiple renowned venues. Among the most frequent publication venues are Cancer Research, Journal of Clinical Oncology, European Journal of Cancer, European Journal of Surgical Oncology, and The Breast.

The following selected recent papers reflect the scope and nature of their research:

  • "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021," published in 2021 in Annals of Oncology
  • "70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age," published in 2021 in The Lancet Oncology
  • "Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials," published in 2021 in The Lancet Oncology
  • "Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial," published in 2022 in Journal of Clinical Oncology
  • "Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023," published in 2023 in Annals of Oncology

Best Publications

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard

  • Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

    Mila Donker;Geertjan van Tienhoven;Marieke E Straver;Philip Meijnen

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

    Saskia Litière;Gustavo Werutsky;Ian S Fentiman;Emiel Rutgers

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer

    Maaike de Boer;Carolien H.M. van Deurzen;Jos A.A.M. van Dijck;George F. Borm

  • Clinical application of the 70-gene profile: the MINDACT trial.

    Fatima Cardoso;Laura Van't Veer;Emiel Rutgers;Sherene Loi

  • Genome-wide association studies identify four ER negative-specific breast cancer risk loci

    Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou

  • Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

    Mila Donker;Saskia Litière;Gustavo Werutsky;Jean Pierre Julien

  • Lymphatic drainage patterns from the breast.

    Susanne H. Estourgie;Omgo E. Nieweg;Renato A. Valdés Olmos;Emiel J. Th. Rutgers

  • Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

    Mila Donker;Marieke E. Straver;Jelle Wesseling;Claudette E. Loo

  • Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study

    Lotte E. Elshof;Konstantinos Tryfonidis;Leen Slaets;A. Elise van Leeuwen-Stok

  • The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

    Stella Mook;Marjanka K. Schmidt;Giuseppe Viale;Giuseppe Viale;Giancarlo Pruneri;Giancarlo Pruneri

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

Frequent Co-Authors

Jelle Wesseling
Jelle Wesseling Leiden University Medical Center
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Fatima Cardoso
Fatima Cardoso Champalimaud Foundation
Omgo E. Nieweg
Omgo E. Nieweg Royal Prince Alfred Hospital
Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Giuseppe Viale
Giuseppe Viale University of Milan
Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative routes in healthcare is increasingly popular for those looking to fast-track their careers in medicine or related fields. Many students consider online direct entry msn programs for non-nurses as a pathway to advanced nursing roles, even for those without a traditional nursing background.

Admission requirements can be a barrier for some, but options like the easiest rn program to get into help open doors for aspiring nurses who may not have top academic scores or healthcare experience.

For those interested in administrative healthcare roles, options such as online medical coding classes with financial aid offer flexibility and support while preparing graduates for in-demand positions.

Some programs are also minimizing standardized test barriers. For example, lpn to rn programs without teas test provide a seamless path for licensed practical nurses to advance their credentials.

With so many accessible online programs, students can find a career pathway that matches their interests and needs—often with greater flexibility, reduced prerequisites, and support options like financial aid.

Best Scientists Citing Emiel J. Th. Rutgers

Trending Scientists

Recently Published Articles